IVF (INVO Fertility) YoY EBITDA Growth: 100.52% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVF INVO Fertility Inc IVF
35 GF Score
Price $1.13
GF Value $4.84
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is INVO Fertility YoY EBITDA Growth?

INVO Fertility IVF +0.88% 35 YoY EBITDA Growth is 100.52% as of Jun. 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $4.84 (Possible Value Trap). The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. INVO Fertility's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 100.52%.

INVO Fertility's EBITDA per Share for the three months ended in Jun. 2026 was $0.49.

INVO Fertility YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for INVO Fertility's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

INVO Fertility YoY EBITDA Growth Chart

INVO Fertility Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 45.30 98.41

INVO Fertility Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.98 92.49 100.96 98.32 100.52
IVF
35GF Score
INVO Fertility Inc IVF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

INVO Fertility YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

INVO Fertility's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-29.974--1881.667)/ | -1881.667 |
=98.41 %

INVO Fertility's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.489--93.3)/ | -93.3 |
=100.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 100.52% mean?
INVO Fertility (IVF) has a YoY EBITDA Growth of 100.52% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for INVO Fertility and its competitors.
Is INVO Fertility's YoY EBITDA Growth too high?
INVO Fertility's current YoY EBITDA Growth is 100.52%. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's YoY EBITDA Growth compare to AMIX and AEMD?
INVO Fertility's YoY EBITDA Growth of 100.52% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for INVO Fertility and its competitors. INVO Fertility's current YoY EBITDA Growth is 100.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $4.84, compared to a current price of $1.13 — trading 76.8% below its estimated fair value. The current YoY EBITDA Growth is 100.52%. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For INVO Fertility (IVF), the current YoY EBITDA Growth is 100.52% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is INVO Fertility (IVF) Overvalued in 2026?

Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued. The current stock price of $1.13 is trading 76.8% below its estimated GF Value™ of $4.84. GuruFocus considers INVO Fertility to be Possible Value Trap.

Key valuation signals for IVF:

  • YoY EBITDA Growth: 100.52%
  • GF Value™: $4.84 vs. price of $1.13 (76.8% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INVO Fertility Business Description

Address 5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score

Get the complete analysis for IVF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price
$4.84
GF Value